Total Fair

Value on

the

Balance

Sheet

Quoted

Prices

In Active

Markets

For

Identical

Assets

/Liabilities

(Level 1)

Significant

Other

Observable

Inputs

(Level 2)

Significant

Unobservable

Inputs

(Level 3)

Assets:

Recurring items as of September 30, 2014

Short-term investments available for sale Bonds – corporate issuances

$

39,047,820

$

39,047,820

$

─

$

─

Non-recurring items as of September 30, 2014

In-process research and development

$

25,801,728

$

─

$

─

$

25,801,728

Goodwill

$

1,976,101

$

─

$

─

$

1,976,101

Recurring items as of December 31, 2013

Short-term investments available for sale Bonds – corporate issuances

$

37,156,381

$

37,156,381

$

─

$

─

Liabilities:

Recurring items as of September 30, 2014

Common stock warrant liability

$

398,044

$

─

$

─

$

398,044

Earnout milestone liability

$

13,877,659

$

─

$

─

$

13,877,659

As of December 31, 2013

Common stock warrant liability

$

3,026

$

─

$

─

$

3,026